Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy

被引:24
|
作者
Park, Seong-Mi [1 ]
Kim, Yong-Hyun [1 ]
Ahn, Chul-Min [1 ]
Hong, Soon-Jun [1 ]
Lim, Do-Sun [1 ]
Shim, Wan-Joo [1 ]
机构
[1] Korea Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul 136705, South Korea
来源
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY | 2011年 / 12卷 / 12期
关键词
Integrated backscatter; Strain; Dilated cardiomyopathy; Remodelling; CARDIOVASCULAR MAGNETIC-RESONANCE; CONGESTIVE-HEART-FAILURE; BETA-BLOCKER THERAPY; INTEGRATED BACKSCATTER; END-STAGE; FIBROSIS; DYSFUNCTION; DEPENDENCE; ECHOCARDIOGRAPHY; HYPERTENSION;
D O I
10.1093/ejechocard/jer177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims This study was to evaluate the relationship between ultrasonic tissue characterization by integrated backscatter (IBS) and myocardial deformation assessed by two-dimensional speckled tracking (2DS) imaging for prediction of left ventricular (LV) reverse remodelling in patients with non-ischaemic dilated cardiomyopathy (DCM). Methods and results Forty-five consecutive patients with non-ischaemic DCM were enrolled prospectively. The mean cyclic variation of integrated backscatter (CVIBS) was calculated as the mean of the septal and posterior wall CVIBS. LV global longitudinal, radial, and circumferential peak strain (GLS, GRS, and GCS, respectively) and twist were obtained. LV reverse remodelling was decided with follow-up echocardiography 12 months. The GLS, GRS, and GCS were correlated with the mean CVIBS. The mean CVIBS and GCS were significantly larger in the 24 patients who had LV reverse remodelling than the 21 patients who had no LV reverse remodelling and the GRS tended to be larger; the GLS and twist did not differ between the two groups. The mean CVIBS and GCS were independent predictors of LV reverse remodelling. Conclusion Myocardial deformation assessed by 2DS was related to myocardial fibrosis assessed by IBS. LV reverse remodelling was predicted by mean CVIBS and GCS in patients with non-ischaemic DCM and GCS assessed by 2DS imaging is a simple method and therefore it can be readily used in clinical practice.
引用
收藏
页码:887 / 894
页数:8
相关论文
共 50 条
  • [31] Genetics of recent-onset dilated cardiomyopathy as a predictor of left ventricular reverse remodelling
    Chaloupka, A.
    Krejci, J.
    Piherova, L.
    Grochova, I.
    Binova, J.
    Stranecky, V.
    Kmoch, S.
    Spinarova, L.
    Kubanek, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4050 - 4050
  • [32] Immunocompetent cells in durable ventricular assist device-implanted non-ischaemic dilated cardiomyopathy
    Ayumi Koga-Ikuta
    Satsuki Fukushima
    Hatsue Ishibashi-Ueda
    Naoki Tadokoro
    Takashi Kakuta
    Takurya Watanabe
    Norihide Fukushima
    Ken Suzuki
    Toshihiro Fukui
    Tomoyuki Fujita
    General Thoracic and Cardiovascular Surgery, 2022, 70 : 685 - 693
  • [33] Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors
    Dulak, Elzbieta
    Lubinski, Andrzej
    Bissinger, Andrzej
    Przybylski, Andrzej
    Sterlinski, Maciej
    Filipecki, Artur
    Pazdyga, Anna
    Zienciuk, Agnieszka
    Kempa, Maciej
    Krolak, Tomasz
    Szwed, Hanna
    Trusz-Gluza, Maria
    Kargul, Wlodzimierz
    KARDIOLOGIA POLSKA, 2009, 67 (08) : 837 - 846
  • [34] Immunocompetent cells in durable ventricular assist device-implanted non-ischaemic dilated cardiomyopathy
    Koga-Ikuta, Ayumi
    Fukushima, Satsuki
    Ishibashi-Ueda, Hatsue
    Tadokoro, Naoki
    Kakuta, Takashi
    Watanabe, Takurya
    Fukushima, Norihide
    Suzuki, Ken
    Fukui, Toshihiro
    Fujita, Tomoyuki
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2022, 70 (08) : 685 - 693
  • [35] Comparison of the Effect of Sacubitril/Valsartan on Left Ventricular Systolic Function in Patients with Non-ischaemic and Ischaemic Cardiomyopathy
    Ioannou, Adam
    Metaxa, Sofia
    Simon, Steny
    Mandal, Amit K. J.
    Missouris, Constantinos G.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (06) : 755 - 762
  • [36] Comparative prognostic importance of measures of left atrial structure and function in non-ischaemic dilated cardiomyopathy
    Hammersley, Daniel J.
    Mukhopadhyay, Srinjay
    Chen, Xiuyu
    Cheng, Leanne
    Jones, Richard E.
    Mach, Lukas
    Curran, Lara
    Yazdani, Momina
    Iacob, Alma
    Lota, Amrit S.
    Khalique, Zohya
    De Marvao, Antonio
    Baruah, Resham
    Guha, Kaushik
    Ware, James S.
    Gregson, John
    Zhao, Shihua
    Pennell, Dudley J.
    Tayal, Upasana
    Prasad, Sanjay K.
    Halliday, Brian P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 25 (11) : 1566 - 1574
  • [37] Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience
    Verma, Atul
    Wulffhart, Zaev
    Lakkireddy, Dhanunjaya
    Khaykin, Yaariv
    Kaplan, Alexander
    Sarak, Bradley
    Biria, Mazda
    Pillarisetti, Jayasree
    Bhat, Pradeep
    Di Biase, Luigi
    Constantini, Otto
    Quan, Kara
    Natale, Andrea
    HEART, 2010, 96 (07) : 510 - 515
  • [38] Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy
    Grimm, Wolfram
    Timmesfeld, Nina
    Efimova, Elena
    EUROPACE, 2013, 15 (11): : 1594 - 1600
  • [39] Comparison of the Effect of Sacubitril/Valsartan on Left Ventricular Systolic Function in Patients with Non-ischaemic and Ischaemic Cardiomyopathy
    Adam Ioannou
    Sofia Metaxa
    Steny Simon
    Amit K. J. Mandal
    Constantinos G. Missouris
    Cardiovascular Drugs and Therapy, 2020, 34 : 755 - 762
  • [40] Reply to: Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non-ischaemic dilated cardiomyopathy: a meta-analysis
    Wang, Jie
    Xu, Yuanwei
    Chen, Yucheng
    ESC HEART FAILURE, 2021, 8 (02): : 1728 - 1728